Legal Representation
Attorney
Hoang-chi Truong
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 5, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 5, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 19, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 17, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 17, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 17, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 4, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 2, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 2, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 2, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 2, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 7, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 7, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 18, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 2, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 28, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 28, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 28, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 28, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 20, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 24, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
Class 044
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; Medical analysis services relating to the diagnosis and treatment of person
Additional Information
Design Mark
The mark consists of a circle composed of five rings of horizontal lines extending out, crossed at points by vertical lines, and a sixth inner ring composed of vertical lines connected to the horizontal lines in the outer rings.
Classification
International Classes
042
044